BeStock  
Stocks › Medical Devices › SIBN

Si-Bone SIBN

US equityMarket cap rank #3350Medical Devices
$19.10 −$0.45 (-2.30%)
Market closed · Oct 8, 4:10 am ET · Last extended-hours $19.10 0.00%
Open$19.27
Prev close$19.55
Day range$18.98 – $19.69
Volume547.6K
Market cap$856.03M
P/E (TTM)–
Dividend yield–

Earnings

Average move on report day±10.6%last 16 reports
Closed higher8 of 1650% of the time
Best reaction+19.7%
Worst reaction-24.3%

Stock move on the day after each report

-2.1%2023/Q3-13.5%2023/Q4+8.3%2024/Q1+1.3%2024/Q2-15.9%2024/Q3+5.6%2024/Q4+15.4%2025/Q1-10.6%2025/Q2+16.2%2025/Q3-2.1%2025/Q4+19.7%2026/Q1-0.1%2026/Q2
QuarterReport dateTimingImplied moveActual moveVersus implied
2026/Q23 Aug 2026After Market±12.9%-0.05%Within range
2026/Q111 May 2026After Market±16.5%+19.72%Bigger than priced
2025/Q423 Feb 2026After Market±18.4%-2.11%Within range
2025/Q310 Nov 2025After Market±14.3%+16.20%Bigger than priced
2025/Q24 Aug 2025After Market±11.7%-10.61%Within range
2025/Q15 May 2025After Market±15.7%+15.44%Within range
2024/Q424 Feb 2025After Market±14.6%+5.55%Within range
2024/Q312 Nov 2024After Market±12.8%-15.93%Bigger than priced
2024/Q25 Aug 2024After Market±18.5%+1.28%Within range
2024/Q16 May 2024After Market±10.7%+8.29%Within range
2023/Q426 Feb 2024After Market–-13.53%–
2023/Q36 Nov 2023After Market±12.3%-2.06%Within range
2023/Q27 Aug 2023After Market±14.0%-11.17%Within range
2023/Q11 May 2023After Market±16.0%+7.17%Within range
2022/Q427 Feb 2023After Market–+16.74%–
2022/Q37 Nov 2022After Market–-24.33%–

"Implied move" is the size of move the options market was pricing ahead of the report. Move is the stock’s change on the first session after the release.

Latest reported quarter: Q2, ended Jun 2026

Revenue$56.01M+15.2% YoY
Operating profit-$4.81M+31.4% YoY
Net profit-$4.09M+33.6% YoY
Diluted EPS-$0.09+35.7% YoY
Free cash flow-$768,000.00+60.1% YoY
Operating cash flow$777,000.00

Revenue, last 8 quarters

$40.3MSep '24$49.0MDec '24$47.3MMar '25$48.6MJun '25$48.7MSep '25$56.3MDec '25$52.6MMar '26$56.0MJun '26

Net profit, last 8 quarters

$-6.6MSep '24$-4.5MDec '24$-6.5MMar '25$-6.2MJun '25$-4.6MSep '25$-1.6MDec '25$-4.3MMar '26$-4.1MJun '26

Profitability & balance sheet

Gross margin79.5%
Operating margin-8.3%
Net margin-6.9%
Return on equity-8.3%
Return on assets-6.1%
Return on invested capital-8.2%
Current ratio9.15
Liabilities / assets26.7%
Cash & investments$145.94M
Total debt$42.37M
Net cash (debt)$103.57M

Discussion

No comments yet — be the first to weigh in on SIBN.

Leave a comment

Scroll to Top